You have 9 free searches left this month | for more free features.

Mitoxantrone

Showing 51 - 75 of 438

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

Completed
  • Acute,Leukemia, Lymphoid
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 2, 2022

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Leukemia Trial in Shanghai (CLAM+PBSC)

Suspended
  • Leukemia
  • Shanghai, China
    Rui Jin Hospital, Department of Hematology
Nov 23, 2021

Platinum-resistant Ovarian Cancer Trial in China (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))

Recruiting
  • Platinum-resistant Ovarian Cancer
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • Chongqing, Chongqing, China
  • +6 more
May 31, 2021

Advanced Gastric Carcinoma Trial in China (Mitoxantrone Hydrochloride Liposome, intravenous injection)

Recruiting
  • Advanced Gastric Carcinoma
  • Mitoxantrone Hydrochloride Liposome, intravenous injection
  • Beijing, Beijing, China
  • +8 more
May 31, 2021

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)

Completed
  • Non-Hodgkins Lymphoma
  • Fort Myers, Florida
  • +1 more
Feb 21, 2022

Advanced Hepatocellular Carcinoma Trial (Liposome-entrapped Mitoxantrone Hydrochloride Injection)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Liposome-entrapped Mitoxantrone Hydrochloride Injection
  • (no location specified)
Jun 14, 2021

Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)

Withdrawn
  • Leukemia
  • recombinant interferon alfa
  • +7 more
  • Chicago, Illinois
  • +3 more
Oct 6, 2021

AML Trial in Boston (Etoposide, Cytarabine, Lenalidomide)

Active, not recruiting
  • AML
  • Boston, Massachusetts
  • +2 more
Jan 13, 2021

Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 11, 2020

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Acute Myeloid Leukemia Trial in Germany (HAM, LDAC and/or Mitoxantrone)

Completed
  • Acute Myeloid Leukemia
  • HAM
  • LDAC and/or Mitoxantrone
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +17 more
Aug 2, 2022

Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)

Completed
  • Neuromyelitis Optica
  • +3 more
  • Mitoxantrone
  • Buffalo, New York
    Baird Multiple Sclerosis Center
Dec 23, 2020

Solid Tumours, CNS Tumours Trial in Randwick, Westmead (Mitoxantrone packaged EDV (EnGeneIC Delivery Vehicle))

Terminated
  • Solid Tumours
  • CNS Tumours
  • Mitoxantrone packaged EDV (EnGeneIC Delivery Vehicle)
  • Randwick, New South Wales, Australia
  • +1 more
Jan 30, 2022

Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)

Terminated
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +37 more
Apr 4, 2022

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
Jan 4, 2021

Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 22, 2020

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Acute Myeloid Leukemia Trial in Ulm (chemo (Mitoxantrone, Cytarabine), Placebo, Crenolanib)

Terminated
  • Acute Myeloid Leukemia
  • chemotherapy (Mitoxantrone, Cytarabine)
  • +3 more
  • Ulm, Germany
    Ulm University Hospital
Sep 28, 2021

Breast Cancer Trial in China (Mitoxantrone Hydrochloride Liposome Injection)

Recruiting
  • Breast Cancer
  • Mitoxantrone Hydrochloride Liposome Injection
  • Hefei, Anhui, China
  • +28 more
Jun 15, 2021

Multiple Sclerosis Trial in Isfahan (plasmapheresis)

Completed
  • Multiple Sclerosis
  • plasmapheresis
  • Isfahan, Iran, Islamic Republic of
    Alahra hospital
Aug 27, 2020

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Acute Myeloid Leukemia Trial in France, Germany (panobinostat/LBH589B)

Completed
  • Acute Myeloid Leukemia
  • Paris Cedex 4, France
  • +5 more
Dec 16, 2020